首页> 外国专利> MULTI-TARGET FUSION PROTEIN USED FOR BLOCKING VASCULAR ENDOTHELIAL GROWTH AND ACTIVATING T CELLS, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

MULTI-TARGET FUSION PROTEIN USED FOR BLOCKING VASCULAR ENDOTHELIAL GROWTH AND ACTIVATING T CELLS, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

机译:用于阻断血管内皮生长和激活T细胞的多目标融合蛋白,以及包含该蛋白的药物组合物

摘要

The present invention provides a multi-target fusion protein, used for blocking vascular endothelial growth and activating T cells, comprising (i) a vascular endothelial growth repression domain; (ii) an Fc region of immunoglobulin; and (iii) CD80 extracellular domain (ECD). The present invention also provides a polynucleotide coding for the multi-target fusion protein, a carrier comprising the polynucleotide, a host cell comprising the polynucleotide or the carrier, and a pharmaceutical composition comprising the multi-target fusion protein and an anti-PD1 antibody. The multi-target fusion protein and pharmaceutical composition thereof may treat or prevent cancers in human subjects.
机译:本发明提供了用于阻断血管内皮生长和活化T细胞的多靶融合蛋白,其包含(i)血管内皮生长抑制域; (ii)免疫球蛋白的Fc区; (iii)CD80细胞外结构域(ECD)。本发明还提供了编码该多靶融合蛋白的多核苷酸,包含该多核苷酸的载体,包含该多核苷酸或载体的宿主细胞,以及包含该多靶融合蛋白和抗PD1抗体的药物组合物。多靶融合蛋白及其药物组合物可以治疗或预防人类受试者的癌症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号